Clinical trial
VSF-173 Study in Healthy Adult Volunteers for Treatment of Induced Excessive…
NCT00467441 · Vanda Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00467441 |
|---|---|
| Title | VSF-173 Study in Healthy Adult Volunteers for Treatment of Induced Excessive Sleepiness |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Investigate the Efficacy and Safety of VSF-173 and Matching Placebo in Healthy Male and Female Subjects With Induced Excessive Sleepiness |
| Lead sponsor | Vanda Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Excessive Somnolence |
| Intervention type | Drug |
| Interventions | VSF-173 |
| Enrollment | 60 |
| First posted | Apr 30, 2007 |
| Last update posted | Nov 2, 2007 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: